ArticleJournal of thoracic disease2026
Day 3 blood urea nitrogen and discharge disposition in patients with pleural infection: a multicenter prospective study.
Article in Journal of thoracic disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Although the RAPID score (renal, age, purulence, infection source, and dietary factors) is a validated predictor of mortality in pleural infection, the prognostic value of laboratory measurements obtained during early treatment remains uncertain. We evaluated whether day 3 laboratory markers, particularly blood urea nitrogen (BUN), were associated with failure to return to the pre-admission residence or care environment. Methods: This multicenter prospective observational study included 81 patients with pleural infection across 13 hospitals in Japan. Patients with complete baseline and day 3 data for BUN, C-reactive protein (CRP), albumin, and creatinine were included in the primary analysis. Multivariable Firth logistic regression models evaluated each day 3 laboratory marker after adjustment for its corresponding baseline value, age, and Eastern Cooperative Oncology Group (ECOG) performance status. An exploratory sensitivity analysis excluded patients deemed unfit for surgery at baseline. The primary outcome was failure to return to the pre-admission residence or care environment at the end of the index hospitalization. Results: Among 81 patients, 25 (30.9%) did not return to their pre-admission residence or care environment. Day 3 BUN was not significantly associated with failure to return in the primary analysis [adjusted odds ratio (OR) per 5 mg/dL, 1.12; 95% confidence interval (CI): 0.91-1.47; P=0.30]. Day 3 CRP, albumin, and creatinine were also not significantly associated with the outcome. Older age was significantly associated with failure to return in all four models. In the exploratory sensitivity cohort of 70 patients, higher day 3 BUN was associated with failure to return (adjusted OR per 5 mg/dL, 1.60; 95% CI: 1.08-2.62; P=0.02). Conclusions: Day 3 BUN and other routinely measured laboratory markers were not significantly associated with discharge disposition in the primary adjusted analysis. The association observed for day 3 BUN in the restricted sensitivity analysis should be considered hypothesis-generating and requires validation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.